AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

PMV Pharmaceuticals, Inc.

$1.31 +$0.08 (+6.50%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$1.35
Day Range
$1.21$1.34
Year Range
$1.02$1.91
Market Cap
69.86M
AVG Volume
576.49K
Trailing/Forward PE
-0.92/-
PEG ratio
0.04
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
NASDAQUS
Net Income (USD) · A
-80M-60M-40M-20M02019202020212022202320242025
PMVP Net Income (USD) by year
PeriodNet Income (USD)
2025-77.74M
2024-58.71M
2023-68.96M
2022-73.32M
2021-57.85M
2020-34.44M
2019-25.34M
Operating Income (USD) · A
-100M-75M-50M-25M02019202020212022202320242025
PMVP Operating Income (USD) by year
PeriodOperating Income (USD)
2025-86.21M
2024-85.45M
2023-80.13M
2022-77.04M
2021-58.29M
2020-34.94M
2019-26.64M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: PMVP

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 11 Nov 2026.

PMV Pharmaceuticals, Inc.
PMVP
Stockpicker

Video analysis: PMVP

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PMVP

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.